[{"uuid": "b81a5fff-e3fd-351b-bf0a-6c123381b246", "title": "Antibiotic Collaboration and Licensing Deals Trends and Analysis Report 2024: Access 133 Agreements Signed by the World's Leading Biopharma Companies", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/antibiotic-collaboration-licensing-deals-trends-142200409.html", "providerPublishTime": 1738333320, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HP.E8HUfnyGeLtMAKwLgAQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "width": 480, "height": 58, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/KPtVInxraKsLNBMRw1U5aw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "333004af-162b-3d8f-adb5-f00faafcb20a", "title": "Hoth Therapeutics Regains Compliance With Nasdaq Listing Rule", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/hoth-therapeutics-regains-compliance-nasdaq-153237363.html", "providerPublishTime": 1737732757, "type": "STORY", "relatedTickers": ["HOTH"]}, {"uuid": "ac6ffee0-fcae-3122-a2c0-ab919b58c4b2", "title": "Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/hoth-therapeutics-regains-compliance-nasdaq-132900951.html", "providerPublishTime": 1737725340, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/rdaGJVxssbv4muuTO7wP_A--~B/aD02ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 400, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/nrTuwjYGVmxlVN_MPpNlIA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HOTH"]}, {"uuid": "044bc87a-3779-3d6e-9129-f3543f4b056d", "title": "Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/hoth-therapeutics-expands-intellectual-property-132900418.html", "providerPublishTime": 1737466140, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/rdaGJVxssbv4muuTO7wP_A--~B/aD02ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 400, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/nrTuwjYGVmxlVN_MPpNlIA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HOTH"]}, {"uuid": "1f3eb0bb-b3a8-33f4-a8d0-9f11ec54cdeb", "title": "7 Financial Habits That Could Cost You Thousands Every Year", "publisher": "GOBankingRates", "link": "https://finance.yahoo.com/news/7-financial-habits-could-cost-170018455.html", "providerPublishTime": 1737651618, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Yjmy5M54_wsGPjqLOhENBQ--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/gobankingrates_644/425dde18e25f5cdd4eec78f21cebe34f", "width": 1920, "height": 1080, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/c7mhHRY7Y21D6ZTCN31TGw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/gobankingrates_644/425dde18e25f5cdd4eec78f21cebe34f", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "62f76540-6f6d-3741-a65d-d6004ae36a88", "title": "Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/hoth-therapeutics-attend-sequire-investor-132900542.html", "providerPublishTime": 1737120540, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/rdaGJVxssbv4muuTO7wP_A--~B/aD02ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 400, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/nrTuwjYGVmxlVN_MPpNlIA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HOTH"]}, {"uuid": "b4e07457-fd77-39de-8be6-4ae52fa5bcc3", "title": "The Zacks Analyst Blog Moderna, Regeneron, Intellia  Sage and GSK", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/zacks-analyst-blog-moderna-regeneron-071200631.html", "providerPublishTime": 1737097920, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OcLKRvy7N6mVxmoeElXmzg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/QsbwLbGTzoopTGcMQZhtug--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["REGN", "NTLA", "MRNA", "SAGE"]}, {"uuid": "061aabc7-89af-3fdc-a041-9c1487094135", "title": "Hoth Therapeutics Affirms No Plan to Raise Fresh Capital", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/hoth-therapeutics-affirms-no-plan-184453840.html", "providerPublishTime": 1736361893, "type": "STORY", "relatedTickers": ["HOTH"]}, {"uuid": "f0e1bd26-a517-3b1c-8671-6350057f1609", "title": "Biotech Stock Roundup: MRNA, NTLA Down on Updates, SAGE Up on Biogen's Offer & Other Updates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biotech-stock-roundup-mrna-ntla-170000544.html", "providerPublishTime": 1737046800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.WQmSb1MJO1_eLnmBVS1zA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pa5q6Axi5bBp9pCuwXBcUg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["REGN", "MRNA", "NTLA", "BIIB"]}, {"uuid": "18d03282-3e0c-3827-a824-09ce56e3621f", "title": "HOTH Stock Soars as Skin Toxicity Study in Cancer Patients Meets Goal", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/hoth-stock-soars-skin-toxicity-154100180.html", "providerPublishTime": 1736350860, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/m0Rr7oODNfAbxFuy._sxVg--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b06062bbbdb1d9856d625682b32ea844", "width": 620, "height": 413, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/8NxwWbIRHeFCVgy0nONm2A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/b06062bbbdb1d9856d625682b32ea844", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HOTH"]}, {"uuid": "04a10df1-591e-353b-a601-38cd38061926", "title": "Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/hoth-therapeutics-responds-market-rumors-182700293.html", "providerPublishTime": 1736360820, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/rdaGJVxssbv4muuTO7wP_A--~B/aD02ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 400, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/nrTuwjYGVmxlVN_MPpNlIA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HOTH"]}, {"uuid": "39fe6727-7458-312f-a903-ce40713f9035", "title": "Hoth Therapeutics Says Interim Trial Results Show Drug to Mitigate Skin Cancer Treatment Toxicity Met Efficacy Endpoint", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/hoth-therapeutics-says-interim-trial-144240200.html", "providerPublishTime": 1736260960, "type": "STORY", "relatedTickers": ["HOTH"]}, {"uuid": "b93f9368-29b6-3a68-a1cd-ba1e3d59bbef", "title": "Hoth Therapeutics Achieves Breakthrough in Phase 2a Trial: HT-001 Delivers 100% Success in Combating Cancer Treatment Skin Toxicities", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/hoth-therapeutics-achieves-breakthrough-phase-132900939.html", "providerPublishTime": 1736256540, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/rdaGJVxssbv4muuTO7wP_A--~B/aD02ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 400, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/nrTuwjYGVmxlVN_MPpNlIA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HOTH"]}, {"uuid": "e8764d40-aecc-3c1a-8fdd-0886e6b582d9", "title": "Hoth Therapeutics Soars 215% on Breakthrough Cancer Treatment Success", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/hoth-therapeutics-soars-215-breakthrough-191040577.html", "providerPublishTime": 1736277040, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/i00gJ_aFxHHLjDZatWAysQ--~B/aD0zNjc7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/107289ced6e8b2ded9f6d7c330bf5ada", "width": 550, "height": 367, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/A2P6BZAy2ltYB2Z8H_JIWw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/107289ced6e8b2ded9f6d7c330bf5ada", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HOTH"]}, {"uuid": "2b02ebd6-355a-3cc4-a704-5eff6afcd37c", "title": "Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biotech-stock-roundup-nmra-plunges-184800572.html", "providerPublishTime": 1736448480, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.WQmSb1MJO1_eLnmBVS1zA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pa5q6Axi5bBp9pCuwXBcUg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HOTH", "NMRA", "TEVA"]}, {"uuid": "07749033-5dfd-3978-8983-1fbe310299f9", "title": "Top Midday Gainers", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-midday-gainers-182920925.html", "providerPublishTime": 1736274560, "type": "STORY", "relatedTickers": ["HOTH"]}, {"uuid": "d7c098b5-fcd7-3328-b0d5-1ef790ecefce", "title": "Hoth Therapeutics Enters Patent Deal With Veterans Affairs Department to Develop Obesity Treatment", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/hoth-therapeutics-enters-patent-deal-155207961.html", "providerPublishTime": 1735228327, "type": "STORY", "relatedTickers": ["HOTH"]}, {"uuid": "875ec30b-c16a-34de-af0f-0d474e891acf", "title": "Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/hoth-therapeutics-enters-partnership-department-125800158.html", "providerPublishTime": 1735217880, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/rdaGJVxssbv4muuTO7wP_A--~B/aD02ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 400, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/nrTuwjYGVmxlVN_MPpNlIA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a168928171a9653a66d38f6c5e666beb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HOTH"]}, {"uuid": "6c0486e0-9121-32d7-ad54-55cb90669b5b", "title": "Sector Update: Health Care Stocks Advance Late Afternoon", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-advance-205845263.html", "providerPublishTime": 1736283525, "type": "STORY", "relatedTickers": ["SYK", "CTXR"]}, {"uuid": "2f1f43a8-716c-3c3e-9454-b5921110eeee", "title": "Sector Update: Health Care Stocks Rise in Afternoon Trading", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-185842969.html", "providerPublishTime": 1736276322, "type": "STORY"}]